Unlock this StockReport nowClick to Unlock

BB Biotech AG

BION CHF66.05 -3.3  -4.8%
23/10/18

Momentum
Relative Strength (%)
1m
3m
1yr
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
vs.
market
vs.
industry
Growth & Value
Margin of Safety (beta)
Screens Passed
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Dec 2012 2013 2014 2015 2016 2017 TTM 2018E 2019E CAGR / Avg
Revenue CHFm
Operating Profit CHFm
Net Profit CHFm
EPS Reported CHF
EPS Normalised CHF
EPS Growth %
PE Ratio x
PEG x
Profitability
Operating Margin %
ROA %
ROCE %
ROE %
Cashflow
Op. Cashflow ps CHF
Capex ps CHF
Free Cashflow ps CHF
Last ex-div: 15th Mar, paid: 19th Mar more... Dividends
Dividend ps CHF
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc CHFm
Working Capital CHFm
Net Fixed Assets CHFm
Net Debt CHFm
Book Value CHFm
Average Shares m
Book Value ps CHF +24.1%

FINANCIAL BRIEF: For the nine months ended 30 September 2018, BB BIOTECH AG revenues decreased 71% to SF257.7M. Net income decreased 80% to SF171.5M. Revenues reflect Unrealized Gains/Losses on Securities decrease of 60% to SF257.1M, Realized G/L on Securities decrease from SF227.7M to -SF20.1M, Dividend Income decrease of 15% to SF4.9M. Net income also reflects Management fees increase of 17% to SF30.9M (expense). more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score
A-
A-
Other Ratios
Leverage (ttm) Total -Intang +Pension
Gross Gearing %
Net Gearing %
Cash / Assets %
vs.
market
vs.
industry
Recent History
Latest interim period (ended 30th Sep '18) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Dec 2018
31st Dec 2019

Price Target: CHF73.7
(+6.31% above Price)
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: -6.6% (CHF) (CHF) (CHF) (CHF) (CHF) (CHF)
Consensus Estimate
1m Change
3m Change
2 brokers Broker Consensus Trend
Broker Recommendations for BB Biotech AG
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts: 0 0 2 1 0

Named Brokers and Analysts
Deutsche Bank , Equita SIM Martino de Ambroggi , ESN/ equinet Bank (Germany) Dennis Berzhanin , ODDO BHF Igor Kim, CFA , Baader Helvea Equity Research Bruno Bulic ,

Profile Summary

BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s portfolio comprises between 20 and 35 companies and includes such companies as Celgene, Actelion, Vertex Pharmaceuticals, Gilead, Novo Nordisk, Incyte, Isis Pharmaceuticals, Immunogen, Halozyme Therapeutics, Ariad Pharmaceuticals, Biomarin Pharmaceutical, Alexion Pharmaceuticals, Optimer Pharmaceuticals, Achillion Pharmaceuticals, Swedish Orphan Biovitrum, Dendreon, Bavarian Nordic, Lupin, Glenmark Pharmaceuticals, Strides Arcolab, Endocyte, Probiodrug, and Idenix Pharmaceuticals.

Directors: Erich Hunziker (CHM) 64, Clive Meanwell (VCH) 60, Michael Hutter (CFO) , Tanja Chicherio (DMK) , Silvia Schanz (DIR) , Maria-Grazia Iten-Alderuccio (DIR) , Claude Mikkelsen (DIR) , Maurizio Bernasconi (OTH) , Jan Bootsma (OTH) , Felicia Flanigan (OTH) , Klaus Strein (DRC) ,

No. of Employees: n/a No. of Shareholders: n/a


Last Annual December 31st, 2017
Last Interim September 30th, 2018
Incorporated November 10, 1993
Public Since November 8, 2006
Shares in Issue 55,400,000
Free Float 55.4m (100.0%)
Sector Financials
Industry Holding Companies
Index
Exchange SIX Swiss Exchange
Eligible for an ISA? a SIPP?

BION Share Price Performance BIONQuote
CHF66.05
-3.3  -4.8%
Traded 4:30pm · Minimum 15 min delayed · NMS:

Latest BION News Announcements (delayed)

Upcoming BION Events

Recent ↓
Friday 20th July, 2018
Q2 2018 BB Biotech AG Earnings Release
Thursday 12th July, 2018
Preliminary Q2 2018 BB Biotech AG Earnings Release
Friday 20th April, 2018
Q1 2018 BB Biotech AG Earnings Release
Friday 16th February, 2018
Q4 2017 BB Biotech AG Earnings Release
Friday 20th October, 2017
Q3 2017 BB Biotech AG Earnings Release
Friday 21st July, 2017
Q2 2017 BB Biotech AG Earnings Release
Wednesday 21st June, 2017
BB Biotech AG at Citi European Healthcare Conference
Friday 21st April, 2017
Q1 2017 BB Biotech AG Earnings Release
Tuesday 21st March, 2017
BB Biotech AG at Borsa Italiana Star Conference
Monday 20th March, 2017
Dividend For BION
Thursday 16th March, 2017
BB Biotech AG Annual Shareholders Meeting
Friday 17th February, 2017
Q4 2016 BB Biotech AG Earnings Release
Friday 20th January, 2017
Full Year 2016 BB Biotech AG Portfolio Release
Friday 21st October, 2016
Q3 2016 BB Biotech AG Earnings Release
Friday 22nd July, 2016
Q2 2016 BB Biotech AG Earnings Release
Friday 22nd April, 2016
Q1 2016 BB Biotech AG Earnings Release
Wednesday 13th April, 2016
Preliminary Q1 2016 BB Biotech AG Earnings Release
Tuesday 29th March, 2016
BB Biotech AG Split For BION.S
Monday 21st March, 2016
Dividend For BION.S
Monday 21st March, 2016
Dividend For BION.S


Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2018.


Should you buy BION

Access BION Analytics Now!

FREE TRIAL or TAKE THE TOUR
Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis